Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
  Follow this preprint

Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label randomized clinical trial (DOXYCOV)

Eugene Sobngwi, Sylvain Zemsi, Magellan Guewo-Fokeng, Jean-Claude Katte, Charles Kounfack, Liliane Mfeukeu-Kuate, Armel Zemsi, Yves Wasnyo, Antoinette Assiga Ntsama, Arnaud Ndi-Manga, Joelle Sobngwi-Tambekou, William Ngatchou, Charlotte Moussi Omgba, Jean Claude Mbanya, Pierre Ongolo Zogo, Pierre Joseph Fouda
doi: https://doi.org/10.1101/2021.07.25.21260838
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2021.07.25.21260838
History 
  • July 29, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Eugene Sobngwi1,2,3,4,*,
  2. Sylvain Zemsi1,3,
  3. Magellan Guewo-Fokeng2,3,4,
  4. Jean-Claude Katte2,3,
  5. Charles Kounfack1,5,
  6. Liliane Mfeukeu-Kuate1,2,
  7. Armel Zemsi1,
  8. Yves Wasnyo1,3,
  9. Antoinette Assiga Ntsama1,
  10. Arnaud Ndi-Manga1,3,
  11. Joelle Sobngwi-Tambekou3,
  12. William Ngatchou6,
  13. Charlotte Moussi Omgba7,
  14. Jean Claude Mbanya1,2,4,
  15. Pierre Ongolo Zogo1,2,8 and
  16. Pierre Joseph Fouda1,2
  1. 1Yaounde Central Hospital, Yaounde, Cameroon
  2. 2Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon
  3. 3RSD Institute, Yaounde, Cameroon
  4. 4The Biotechnology Centre, University of Yaounde 1, Yaounde, Cameroon
  5. 5Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon
  6. 6Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
  7. 7Regional Delegation of Public Health, Centre Region, Ministry of Public Health, Cameroon
  8. 8Center for the Development of Good Practices in Health, Yaounde, Cameroon
  1. ↵*Corresponding author
    Prof. Eugene Sobngwi, Department of Internal Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon, Yaounde Central Hospital, and RSD Institute, Yaounde, Cameroon, Email: eugene.sobngwi{at}fmsb-uy1.cm Tel : 675088750
Back to top
Posted July 29, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label randomized clinical trial (DOXYCOV)
Eugene Sobngwi, Sylvain Zemsi, Magellan Guewo-Fokeng, Jean-Claude Katte, Charles Kounfack, Liliane Mfeukeu-Kuate, Armel Zemsi, Yves Wasnyo, Antoinette Assiga Ntsama, Arnaud Ndi-Manga, Joelle Sobngwi-Tambekou, William Ngatchou, Charlotte Moussi Omgba, Jean Claude Mbanya, Pierre Ongolo Zogo, Pierre Joseph Fouda
medRxiv 2021.07.25.21260838; doi: https://doi.org/10.1101/2021.07.25.21260838
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.